share_log

PharmaCyte Biotech | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Iroquois Master Fund Ltd.(4.99%),Iroquois Capital Management, LLC(4.99%), etc.

PharmaCyte Biotech | SC 13D/A:超过5%持股股东披露文件(修正)-Iroquois Master Fund Ltd.(4.99%),Iroquois Capital Management, LLC(4.99%)等

SEC announcement ·  2023/06/16 17:22
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息